Understanding lipid profile changes induced by specific Nur77 modulators in the lipid-lowering process is crucial to exploring the underlying mechanism of their anti-obesity effects. This evidence concerns the gene NR4A1 and obesity due to melanocortin 4 receptor deficiency.